Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carl N. Kraus currently holds 282,475 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl N. Kraus has been a net seller of AQST stock. They have purchased $0 and sold $141.9K worth of shares.
Carl N. Kraus's most recent insider trade was on Oct 15, 2025, when they sold 20,272 shares at $7.00 per share.
Carl N. Kraus serves as Executive at Aquestive Therapeutics, Inc. (AQST). They have executed 5 insider transactions totaling $141.9K over their tenure at the company.
Carl N. Kraus holds the position of Executive at Aquestive Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Carl N. Kraus has shown a selling trading pattern, with $0 in total purchases and $141.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carl N. Kraus was on Oct 15, 2025, when they sold $141.9K worth of AQST shares. This transaction involved 20,272 shares at $7.00 per share.
Carl N. Kraus currently owns 282,475 shares of Aquestive Therapeutics, Inc. (AQST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carl N. Kraus's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carl N. Kraus has 5 Form 4 filings on record as an insider at Aquestive Therapeutics, Inc..
Set alerts for Carl N. Kraus and 40,000+ other insiders.